Sulphonylurea usage in melioidosis is associated with severe disease and suppressed immune response.
BACKGROUND: Melioidosis is a problem in the developing tropical regions of Southeast Asia and Northern Australia where the the Gram negative saprophytic bacillus Burkholderia pseudomallei is endemic with the risk of fulminant septicaemia. While diabetes mellitus is a well-established risk factor for...
Saved in:
Main Authors: | Xiang Liu (Author), Geraldine Foo (Author), Wan Peng Lim (Author), Sharada Ravikumar (Author), Siew Hoon Sim (Author), Mar Soe Win (Author), Jessamine Geraldine Goh (Author), Joan Hui Juan Lim (Author), Ying Hui Ng (Author), Dale Fisher (Author), Chin Meng Khoo (Author), Gladys Tan (Author), Louis Yi Ann Chai (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What's next after metformin? focus on sulphonylurea: add-on or combination therapy
by: Lim PC, et al.
Published: (2015) -
Melioidosis: Clinical impact and public health threat in the tropics.
by: Ramar Perumal Samy, et al.
Published: (2017) -
Fluoroenesulphonamides: N-sulphonylurea isosteres showing nanomolar selective cancer-related transmembrane human carbonic anhydrase inhibition
by: Benoit Métayer, et al.
Published: (2018) -
The Treatment of Melioidosis
by: Timothy J.J. Inglis
Published: (2010) -
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
by: Degli Esposti L, et al.
Published: (2014)